The Medicines Company of the US has completed the acquisition of ProFibrix BV following the successful completion of a Phase 3 trial of the Dutch company’s hospital product – a sealant to stop bleeding during and after surgery. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
